<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00396981</url>
  </required_header>
  <id_info>
    <org_study_id>T4902</org_study_id>
    <secondary_id>BSC0015</secondary_id>
    <nct_id>NCT00396981</nct_id>
  </id_info>
  <brief_title>MAPS Trial: Matrix And Platinum Science</brief_title>
  <acronym>MAPS</acronym>
  <official_title>A Prospective, Randomized, Multicenter Trial Investigating Matrix 2® and GDC® Detachable Coils for the Treatment of Intracranial Saccular Aneurysms</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Stryker Neurovascular</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Stryker Neurovascular</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Primary Objectives:

        -  To establish Target Aneurysm Recurrence (TAR) rates for Matrix 2® and GDC® Coils used
           for the treatment of intracranial saccular aneurysms. TAR is defined as clinically
           relevant recurrence resulting in: target aneurysm reintervention, rupture/re-rupture
           and/or death from an unknown cause.

        -  To correlate defined angiographic endpoints with TAR rates and assess their predictive
           value, thereby providing a framework to establish clinically relevant endpoints for
           future studies.

      Secondary Objectives:

        -  To evaluate device characteristics, incidence and severity of device-related adverse
           events, including death, neurological deterioration and changes in functional abilities.

        -  To establish angiographic recurrence rates for Matrix 2® and GDC® Coils used for the
           treatment of intracranial saccular aneurysms.

        -  To explore an experimental, quantitative and volumetric endpoint and correlate these
           with existing qualitative assessments.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The endovascular treatment of intracranial aneurysms has become an accepted alternative to
      surgical repair given the many recent advances with neurointerventional devices and
      procedures. The introduction of GDC coils in 1993 provided physicians and their patients a
      less invasive treatment option. Additionally, the results of two large international trials,
      ISAT and ISUIA, have shown the benefits of endovascular treatment over surgery for treatment
      of specific types of aneurysms. One limitation of endovascular coil embolization is aneurysm
      recurrence or recanalization which is not infrequently observed angiographically at follow
      up. Aneurysm recanalization may be a result of aneurysm morphology, anatomic location and
      flow orientation, aneurysm regrowth or the degree of coil compaction. Despite the widespread
      adoption of endovascular aneurysm coiling, there remains much to be learned about the
      efficacy and optimization of this treatment modality.

      The goal of endovascular embolization of intracranial aneurysms is to prevent rupture or
      re-rupture. Fortunately, the incidence of aneurysm rupture following coil embolization is
      very low. Follow-up angiographic analysis to evaluate the occlusion and stability of the
      treated aneurysm provides a surrogate endpoint against which to weigh the likelihood of
      rupture/re-rupture. However, angiographic interpretation is subjective, operator dependent
      and can be influenced by multiple confounding variables.

      The MAPS trial will examine Target Aneurysm Recurrence Rates: clinically relevant recurrence
      rates resulting in target aneurysm reintervention, rupture/re-rupture and/or death from an
      unknown cause for Matrix 2® and GDC® Coils used for the treatment of intracranial saccular
      aneurysms. The trial will compare TAR rates to recurrences measured by angiographic analysis
      and assess the utility of angiographic analysis for predicting clinically relevant
      recurrences.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>March 2007</start_date>
  <completion_date type="Actual">March 2015</completion_date>
  <primary_completion_date type="Actual">January 2011</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Target Aneurysm Recurrence (TAR) Defined as Clinically Relevant Recurrence Resulting in Target Aneurysm Reintervention, Rupture/Re-rupture and/or Death From an Unknown Cause.</measure>
    <time_frame>12 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Angiographic Assessments</measure>
    <time_frame>Reintervention or 12 months</time_frame>
    <description>Number of participants with angiographic assessment of &quot;complete obliteration&quot;.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Neurological Assessments</measure>
    <time_frame>12 months</time_frame>
    <description>The changes in modified Rankin Scores from pre-procedure to 12-month were measured. the outcome below reflects &quot;same or better&quot;.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Technical Procedure Success</measure>
    <time_frame>Post-procedure</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Target Aneurysm Recurrence</measure>
    <time_frame>2 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Target Aneurysm Recurrence</measure>
    <time_frame>3 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Target Aneurysm Recurrence</measure>
    <time_frame>5 years</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">626</enrollment>
  <condition>Intracranial Aneurysms</condition>
  <arm_group>
    <arm_group_label>Matrix 2® Coils</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Matrix 2® Coils for endovascular aneurysm occlusion</description>
  </arm_group>
  <arm_group>
    <arm_group_label>GDC® Coils</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>GDC® Coils for endovascular aneurysm occlusion</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Matrix 2® coils for endovascular aneurysm occlusion</intervention_name>
    <description>endovascular aneurysm occlusion coil</description>
    <arm_group_label>Matrix 2® Coils</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>GDC® coils for endovascular aneurysm occlusion</intervention_name>
    <description>endovascular aneurysm occlusion coil</description>
    <arm_group_label>GDC® Coils</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Patient is between 18 and 80 years of age (inclusive).

          2. Patient has a documented untreated intracranial saccular aneurysm 4-20 mm diameter
             angiographic lumen, ruptured or unruptured, suitable for embolization with coils.

          3. Both GDC® Coils and Matrix 2® Coils (Every attempt should be made to treat with as
             much randomized coil type as possible to achieve optimal occlusion.) are treatment
             options (all shapes allowed with exception of GDC VortX Coil).

          4. Target aneurysm can be adequately coiled at index procedure (NO staged coiling
             procedures). If a Neuroform stent is to be placed during a separate preliminary
             procedure, then screening and enrollment for the coiling procedure must take place
             after the stenting procedure is completed.

          5. Target aneurysm morphology allows for adequate retention of coils within the
             aneurysmal sac without occlusion of the parent artery, as determined by the treating
             physician.

          6. Patient (or patient's legally authorized representative for centers in the United
             States) has provided written informed consent.

          7. Patient is willing and able to comply with protocol follow-up requirements.

        Exclusion Criteria:

          1. Patient is &lt; 18 or &gt; 80 years old.

          2. Target aneurysm is not saccular in nature (mycotic, fusiform, dissecting).

          3. Target aneurysm is &gt; 20 mm maximum luminal dimension, &lt; 4 mm maximum luminal
             dimension.

          4. Target aneurysm has been previously treated by surgery or endovascular therapy.

          5. Target aneurysm is in the physician's estimation unlikely to be successfully treated
             by endovascular techniques.

          6. Patient presents as Hunt and Hess grade IV or V for a ruptured aneurysm.

          7. Patient presents with Modified Rankin Score 4 or 5 at baseline.

          8. Patient is concurrently enrolled in another investigational drug or device study
             unless permission is granted by the sponsor.

          9. Patient has known hypersensitivity to Polyglycolic Polylactic Acid (PGLA), platinum,
             nickel, stainless steel or structurally related compounds found in Matrix 2® Coils
             and/or GDC® Coils.

         10. Patients who have had or could have a severe reaction to contrast agents that cannot
             be adequately pre-medicated prior to the coiling procedure.

         11. Patients who are unable to complete scheduled follow up assessments at the enrolling
             center due to limited life expectancy (&lt; 12 months), comorbidities or geographical
             considerations.

         12. Planned use of adjunctive therapy stents except Neuroform is not allowed.

         13. Patients with Moya-Moya disease, AVMs, AV fistula, intracranial tumors, intracranial
             hematoma (unrelated to target aneurysm), significant atherosclerotic stenosis,
             tortuousity or other conditions preventing access to the target aneurysm.

         14. Patients with multiple aneurysms.

         15. Target aneurysm with significant thrombosis that may increase the likelihood of
             recanalization at the discretion of the investigator.

         16. Female patient has a positive pregnancy assessment at baseline.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>S. Claiborne Johnston, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of California, San Francisco, CA</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Cameron McDougall, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Barrow Neurological Institute, Phoenix, AZ</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Anil Gholkar, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Newcastle Upon Tyne Hospitals, NHS Trust, UK</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>St. Joseph's Hospital Barrow Neurological Institute</name>
      <address>
        <city>Phoenix</city>
        <state>Arizona</state>
        <zip>85013</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Tucson Medical Center</name>
      <address>
        <city>Tucson</city>
        <state>Arizona</state>
        <zip>85712</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Yale-New Haven Hospital</name>
      <address>
        <city>New Haven</city>
        <state>Connecticut</state>
        <zip>06510</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Rush Presbyterian</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60640</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The Universtiy of Iowa</name>
      <address>
        <city>Iowa City</city>
        <state>Iowa</state>
        <zip>52242</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Maryland</name>
      <address>
        <city>Baltimore</city>
        <state>Maryland</state>
        <zip>21201</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Massachusetts General Hospital</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02114</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Massachusetts Worcester</name>
      <address>
        <city>Worcester</city>
        <state>Massachusetts</state>
        <zip>01655</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Providence Detroit</name>
      <address>
        <city>Southfield</city>
        <state>Michigan</state>
        <zip>48075</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>St. Joseph's Hospital</name>
      <address>
        <city>St. Paul</city>
        <state>Minnesota</state>
        <zip>55104</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Saint Luke's Hospital of Kansas City</name>
      <address>
        <city>Kansas City</city>
        <state>Missouri</state>
        <zip>64111</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Barnes Jewish Mallinckrodt Institute of Radiology</name>
      <address>
        <city>St. Louis</city>
        <state>Missouri</state>
        <zip>63110</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sunrise Hospital and Medical Center</name>
      <address>
        <city>Las Vegas</city>
        <state>Nevada</state>
        <zip>89109</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of New Mexico Department of Neurosurgery</name>
      <address>
        <city>Albuquerque</city>
        <state>New Mexico</state>
        <zip>87131</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Stony Brook Medical Center</name>
      <address>
        <city>Stony Brook</city>
        <state>New York</state>
        <zip>11794</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Carolina Neurosurgery &amp; Spine Associates, PA</name>
      <address>
        <city>Charlotte</city>
        <state>North Carolina</state>
        <zip>28207</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cleveland Clinic Foundation</name>
      <address>
        <city>Cleveland</city>
        <state>Ohio</state>
        <zip>44195</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Mercy Health Center</name>
      <address>
        <city>Oklahoma City</city>
        <state>Oklahoma</state>
        <zip>73120</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>OHSU</name>
      <address>
        <city>Portland</city>
        <state>Oregon</state>
        <zip>97239</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Medical University of South Carolina</name>
      <address>
        <city>Charleston</city>
        <state>South Carolina</state>
        <zip>29425</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Fort Sanders Regional Medical Center</name>
      <address>
        <city>Knoxville</city>
        <state>Tennessee</state>
        <zip>37916</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Texas Southwestern Medical Center</name>
      <address>
        <city>Dallas</city>
        <state>Texas</state>
        <zip>75390-8896</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Methodist Hospital</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77030</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Washington Harborview Medical Center</name>
      <address>
        <city>Seattle</city>
        <state>Washington</state>
        <zip>98104</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sacred Heart Providence</name>
      <address>
        <city>Spokane</city>
        <state>Washington</state>
        <zip>99204</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Wisconsin Hospital and Center</name>
      <address>
        <city>Madison</city>
        <state>Wisconsin</state>
        <zip>53792</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Royal Melbourne Hospital</name>
      <address>
        <city>Parkville</city>
        <zip>3052</zip>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Montreal Neurological Institute and Hospital</name>
      <address>
        <city>Montreal</city>
        <state>Quebec</state>
        <zip>H3A 2B4</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Xuan Wu Hospital</name>
      <address>
        <city>Beijing</city>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHU Montpelier</name>
      <address>
        <city>Montpellier</city>
        <zip>34295</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Klinikum Augsburg</name>
      <address>
        <city>Augsburg</city>
        <zip>86156</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Universitaetsklinikum Freiburg</name>
      <address>
        <city>Freiburg</city>
        <zip>79106</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Asklepios Klinik Altona</name>
      <address>
        <city>Hamburg</city>
        <zip>22763</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Universitaetsklinikum des Saarlandes</name>
      <address>
        <city>Homburg/Saar</city>
        <zip>66421</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Instituto Nacional de Neurologia e Neurocirurgia</name>
      <address>
        <city>Mexico City</city>
        <zip>14269</zip>
        <country>Mexico</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Rikshospitalet University Hospital</name>
      <address>
        <city>Oslo</city>
        <zip>0027</zip>
        <country>Norway</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital General</name>
      <address>
        <city>Alicante</city>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Clinico Y provincial</name>
      <address>
        <city>Barcelona</city>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Clinica Ntra Sra Del Rosario Hospital Ruber Internacional</name>
      <address>
        <city>Madrid</city>
        <zip>28056</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Donostia</name>
      <address>
        <city>San Sebastian</city>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Istanbul University Cerrahpaşa Tıp Fakültesi</name>
      <address>
        <city>Kocamustafapasa</city>
        <state>Istanbul</state>
        <zip>34300</zip>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The Walton Centre</name>
      <address>
        <city>Fazakerley</city>
        <state>Liverpool</state>
        <zip>L9 7LJ</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Newcastle General Hospital Department of Neuroradiology</name>
      <address>
        <city>Tyne and Wear</city>
        <zip>NE4 6BE</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Australia</country>
    <country>Canada</country>
    <country>China</country>
    <country>France</country>
    <country>Germany</country>
    <country>Mexico</country>
    <country>Norway</country>
    <country>Spain</country>
    <country>Turkey</country>
    <country>United Kingdom</country>
    <country>United States</country>
  </location_countries>
  <verification_date>January 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 6, 2006</study_first_submitted>
  <study_first_submitted_qc>November 6, 2006</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 8, 2006</study_first_posted>
  <results_first_submitted>February 7, 2013</results_first_submitted>
  <results_first_submitted_qc>January 29, 2014</results_first_submitted_qc>
  <results_first_posted type="Estimate">March 18, 2014</results_first_posted>
  <last_update_submitted>January 19, 2016</last_update_submitted>
  <last_update_submitted_qc>January 19, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 17, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Intracranial saccular aneurysms</keyword>
  <keyword>Endovascular coiling therapy</keyword>
  <keyword>Retreatment</keyword>
  <keyword>Raymond scale</keyword>
  <keyword>Matrix</keyword>
  <keyword>GDC</keyword>
  <keyword>Guglielmi Detachable Coil</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Aneurysm</mesh_term>
    <mesh_term>Intracranial Aneurysm</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <recruitment_details>Enrollment in the study occurred over 31 months at 26 sites in the US and 17 International. Each site was allowed to enroll up to 60 consecutive subjects; recruitment for the study was competitive. The first subject was enrolled on 29 March 2007 and the enrollment completed on 21 October 2009. A total of 626 subjects were enrolled.</recruitment_details>
      <group_list>
        <group group_id="P1">
          <title>Matrix 2® Coils for Endovascular Aneurysm Occlusion</title>
          <description>Matrix 2® Coils for endovascular aneurysm occlusion
Matrix 2® coils for endovascular aneurysm occlusion : endovascular aneurysm occlusion coil</description>
        </group>
        <group group_id="P2">
          <title>GDC® Coils for Endovascular Aneurysm Occlusion</title>
          <description>GDC® Coils for endovascular aneurysm occlusion
GDC® coils for endovascular aneurysm occlusion : endovascular aneurysm occlusion coil</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="311"/>
                <participants group_id="P2" count="315"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="296"/>
                <participants group_id="P2" count="306"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="15"/>
                <participants group_id="P2" count="9"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Matrix 2® Coils for Endovascular Aneurysm Occlusion</title>
          <description>Matrix 2® Coils for endovascular aneurysm occlusion
Matrix 2® coils for endovascular aneurysm occlusion : endovascular aneurysm occlusion coil</description>
        </group>
        <group group_id="B2">
          <title>GDC® Coils for Endovascular Aneurysm Occlusion</title>
          <description>GDC® Coils for endovascular aneurysm occlusion
GDC® coils for endovascular aneurysm occlusion : endovascular aneurysm occlusion coil</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="311"/>
            <count group_id="B2" value="315"/>
            <count group_id="B3" value="626"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="55.7" spread="11.6"/>
                    <measurement group_id="B2" value="54.4" spread="13.2"/>
                    <measurement group_id="B3" value="55.0" spread="12.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="229"/>
                    <measurement group_id="B2" value="211"/>
                    <measurement group_id="B3" value="440"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="82"/>
                    <measurement group_id="B2" value="104"/>
                    <measurement group_id="B3" value="186"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>France</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="17"/>
                    <measurement group_id="B2" value="15"/>
                    <measurement group_id="B3" value="32"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="183"/>
                    <measurement group_id="B2" value="190"/>
                    <measurement group_id="B3" value="373"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Mexico</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="2"/>
                    <measurement group_id="B3" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Canada</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="16"/>
                    <measurement group_id="B2" value="15"/>
                    <measurement group_id="B3" value="31"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Spain</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="46"/>
                    <measurement group_id="B2" value="44"/>
                    <measurement group_id="B3" value="90"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Turkey</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="4"/>
                    <measurement group_id="B2" value="6"/>
                    <measurement group_id="B3" value="10"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Australia</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="3"/>
                    <measurement group_id="B3" value="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Norway</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="6"/>
                    <measurement group_id="B2" value="5"/>
                    <measurement group_id="B3" value="11"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Germany</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="13"/>
                    <measurement group_id="B2" value="10"/>
                    <measurement group_id="B3" value="23"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>China</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="7"/>
                    <measurement group_id="B2" value="9"/>
                    <measurement group_id="B3" value="16"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>United Kingdom</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="17"/>
                    <measurement group_id="B2" value="16"/>
                    <measurement group_id="B3" value="33"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Target Aneurysm Recurrence (TAR) Defined as Clinically Relevant Recurrence Resulting in Target Aneurysm Reintervention, Rupture/Re-rupture and/or Death From an Unknown Cause.</title>
        <time_frame>12 months</time_frame>
        <population>A totoal of 630 subjects were planned for the study. All enrolled MAPS trial subjects' data is included in the ITT anaylsis except for four subjects who were excluded due to the following reasons: one subject did not have an aneurysm and three subjects', a the request of the IRB, due to non GCP compliance in obtaining the inofrmed consent.</population>
        <group_list>
          <group group_id="O1">
            <title>Matrix Coils</title>
            <description>Matrix 2® Coils for endovascular aneurysm occlusion</description>
          </group>
          <group group_id="O2">
            <title>GDC Coils</title>
            <description>GDC® Coils for endovascular aneurysm occlusion</description>
          </group>
        </group_list>
        <measure>
          <title>Target Aneurysm Recurrence (TAR) Defined as Clinically Relevant Recurrence Resulting in Target Aneurysm Reintervention, Rupture/Re-rupture and/or Death From an Unknown Cause.</title>
          <population>A totoal of 630 subjects were planned for the study. All enrolled MAPS trial subjects' data is included in the ITT anaylsis except for four subjects who were excluded due to the following reasons: one subject did not have an aneurysm and three subjects', a the request of the IRB, due to non GCP compliance in obtaining the inofrmed consent.</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="311"/>
                <count group_id="O2" value="315"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="34"/>
                    <measurement group_id="O2" value="35"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
            </group_id_list>
            <groups_desc>Intent-to-Treat, All Subjects (N=626) GDC (N=315) Matrix (N=311) All Subjects (N=626) Subjects Who Met Primary Endpoint 35 (11.1%) 34 (10.9%) 69 (11.0%)</groups_desc>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>This study used a non-inferiority design to demonstrate that the Matrix Coil is non-inferior to the GDC Coil, with a clinically acceptable non-inferiority margin set at 10%. Non-inferiority was used to establish the baseline estimate, which future superiority studies could be conducted. Non-inferiority was shown with a one-sided 95% CI of the difference less than the pre-specified 10% margin</non_inferiority_desc>
            <p_value>0.76</p_value>
            <method>Log Rank</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Angiographic Assessments</title>
        <description>Number of participants with angiographic assessment of &quot;complete obliteration&quot;.</description>
        <time_frame>Reintervention or 12 months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Matrix Coils</title>
            <description>Matrix 2® Coils for endovascular aneurysm occlusion</description>
          </group>
          <group group_id="O2">
            <title>GDC Coils</title>
            <description>GDC® Coils for endovascular aneurysm occlusion</description>
          </group>
        </group_list>
        <measure>
          <title>Angiographic Assessments</title>
          <description>Number of participants with angiographic assessment of &quot;complete obliteration&quot;.</description>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="238"/>
                <count group_id="O2" value="250"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="87"/>
                    <measurement group_id="O2" value="89"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Neurological Assessments</title>
        <description>The changes in modified Rankin Scores from pre-procedure to 12-month were measured. the outcome below reflects &quot;same or better&quot;.</description>
        <time_frame>12 months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Matrix Coils</title>
            <description>Matrix 2® Coils for endovascular aneurysm occlusion</description>
          </group>
          <group group_id="O2">
            <title>GDC Coils</title>
            <description>GDC® Coils for endovascular aneurysm occlusion</description>
          </group>
        </group_list>
        <measure>
          <title>Neurological Assessments</title>
          <description>The changes in modified Rankin Scores from pre-procedure to 12-month were measured. the outcome below reflects &quot;same or better&quot;.</description>
          <units>percentage of participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="311"/>
                <count group_id="O2" value="315"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="90.1"/>
                    <measurement group_id="O2" value="88.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Technical Procedure Success</title>
        <time_frame>Post-procedure</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Matrix Coils</title>
            <description>Matrix 2® Coils for endovascular aneurysm occlusion</description>
          </group>
          <group group_id="O2">
            <title>GDC Coils</title>
            <description>GDC® Coils for endovascular aneurysm occlusion</description>
          </group>
        </group_list>
        <measure>
          <title>Technical Procedure Success</title>
          <units>percentage of participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="311"/>
                <count group_id="O2" value="315"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="96.8"/>
                    <measurement group_id="O2" value="97.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Target Aneurysm Recurrence</title>
        <time_frame>2 years</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Matrix Coils</title>
            <description>Matrix 2® Coils for endovascular aneurysm occlusion</description>
          </group>
          <group group_id="O2">
            <title>GDC Coils</title>
            <description>GDC® Coils for endovascular aneurysm occlusion</description>
          </group>
        </group_list>
        <measure>
          <title>Target Aneurysm Recurrence</title>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="311"/>
                <count group_id="O2" value="315"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="42"/>
                    <measurement group_id="O2" value="42"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Target Aneurysm Recurrence</title>
        <time_frame>3 years</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Matrix Coils</title>
            <description>Matrix 2® Coils for endovascular aneurysm occlusion</description>
          </group>
          <group group_id="O2">
            <title>GDC Coils</title>
            <description>GDC® Coils for endovascular aneurysm occlusion</description>
          </group>
        </group_list>
        <measure>
          <title>Target Aneurysm Recurrence</title>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="311"/>
                <count group_id="O2" value="315"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="43"/>
                    <measurement group_id="O2" value="45"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Target Aneurysm Recurrence</title>
        <time_frame>5 years</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Matrix Coils</title>
            <description>Matrix 2® Coils for endovascular aneurysm occlusion</description>
          </group>
          <group group_id="O2">
            <title>GDC Coils</title>
            <description>GDC® Coils for endovascular aneurysm occlusion</description>
          </group>
        </group_list>
        <measure>
          <title>Target Aneurysm Recurrence</title>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="311"/>
                <count group_id="O2" value="315"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="44"/>
                    <measurement group_id="O2" value="46"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>12 months</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Matrix Coils</title>
          <description>Matrix 2® Coils for endovascular aneurysm occlusion</description>
        </group>
        <group group_id="E2">
          <title>GDC Coils</title>
          <description>GDC® Coils for endovascular aneurysm occlusion</description>
        </group>
      </group_list>
      <serious_events>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="85" subjects_at_risk="311"/>
                <counts group_id="E2" subjects_affected="80" subjects_at_risk="315"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Blood and lymphatic system disorders</title>
            <event_list>
              <event>
                <sub_title>Haemorrhagic anaemia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="311"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="315"/>
              </event>
              <event>
                <sub_title>Thrombocytopenia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="311"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="315"/>
              </event>
              <event>
                <sub_title>Total</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="311"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="315"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>Angina pectoris</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="311"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="315"/>
              </event>
              <event>
                <sub_title>Arrhythmia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="311"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="315"/>
              </event>
              <event>
                <sub_title>Atrial fibrillation</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="311"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="315"/>
              </event>
              <event>
                <sub_title>Atrioventricular block second degree</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="311"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="315"/>
              </event>
              <event>
                <sub_title>Bradycardia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="311"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="315"/>
              </event>
              <event>
                <sub_title>Cardiac failure</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="311"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="315"/>
              </event>
              <event>
                <sub_title>Cardiac failure congestive</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="311"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="315"/>
              </event>
              <event>
                <sub_title>Cardiac valve disease</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="311"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="315"/>
              </event>
              <event>
                <sub_title>Cardiovascular disorder</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="311"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="315"/>
              </event>
              <event>
                <sub_title>Myocardial infarction</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="311"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="315"/>
              </event>
              <event>
                <sub_title>Total</sub_title>
                <counts group_id="E1" events="8" subjects_affected="7" subjects_at_risk="311"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="315"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Ear and labyrinth disorders</title>
            <event_list>
              <event>
                <sub_title>Vertigo</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="311"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="315"/>
              </event>
              <event>
                <sub_title>Total</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="311"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="315"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Eye disorders</title>
            <event_list>
              <event>
                <sub_title>Vision blurred</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="311"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="315"/>
              </event>
              <event>
                <sub_title>Total</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="311"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="315"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Diverticular perforation</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="311"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="315"/>
              </event>
              <event>
                <sub_title>Gastrointestinal fistula</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="311"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="315"/>
              </event>
              <event>
                <sub_title>Gastrointestinal haemorrhage</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="311"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="315"/>
              </event>
              <event>
                <sub_title>Intestinal ischaemia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="311"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="315"/>
              </event>
              <event>
                <sub_title>Oesophagitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="311"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="315"/>
              </event>
              <event>
                <sub_title>Peritonitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="311"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="315"/>
              </event>
              <event>
                <sub_title>Retroperitoneal haemorrhage</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="311"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="315"/>
              </event>
              <event>
                <sub_title>Total</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="311"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="315"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Catheter site discharge</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="311"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="315"/>
              </event>
              <event>
                <sub_title>Catheter site haematoma</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="311"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="315"/>
              </event>
              <event>
                <sub_title>Catheter site haemorrhage</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="311"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="315"/>
              </event>
              <event>
                <sub_title>Death</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="311"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="315"/>
              </event>
              <event>
                <sub_title>Multi-organ failure</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="311"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="315"/>
              </event>
              <event>
                <sub_title>Total</sub_title>
                <counts group_id="E1" events="8" subjects_affected="8" subjects_at_risk="311"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="315"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Hepatobiliary disorders</title>
            <event_list>
              <event>
                <sub_title>Chronic hepatic failure</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="311"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="315"/>
              </event>
              <event>
                <sub_title>Total</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="311"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="315"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Immune system disorders</title>
            <event_list>
              <event>
                <sub_title>Drug hypersensitivity</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="311"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="315"/>
              </event>
              <event>
                <sub_title>Total</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="311"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="315"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>Arthritis bacterial</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="311"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="315"/>
              </event>
              <event>
                <sub_title>Central nervous system infection</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="311"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="315"/>
              </event>
              <event>
                <sub_title>Clostridial infection</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="311"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="315"/>
              </event>
              <event>
                <sub_title>Herpes zoster</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="311"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="315"/>
              </event>
              <event>
                <sub_title>Meningitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="311"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="315"/>
              </event>
              <event>
                <sub_title>Pneumonia</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="311"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="315"/>
              </event>
              <event>
                <sub_title>Pneumonia escherichia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="311"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="315"/>
              </event>
              <event>
                <sub_title>Sepsis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="311"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="315"/>
              </event>
              <event>
                <sub_title>Staphylococcal infection</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="311"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="315"/>
              </event>
              <event>
                <sub_title>Urinary tract infection</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="311"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="315"/>
              </event>
              <event>
                <sub_title>Wound infection</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="311"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="315"/>
              </event>
              <event>
                <sub_title>Total</sub_title>
                <counts group_id="E1" events="14" subjects_affected="11" subjects_at_risk="311"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="315"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Injury, poisoning and procedural complications</title>
            <event_list>
              <event>
                <sub_title>Brain herniation</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="311"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="315"/>
              </event>
              <event>
                <sub_title>Subdural haematoma</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="311"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="315"/>
              </event>
              <event>
                <sub_title>Total</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="311"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="315"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Investigations</title>
            <event_list>
              <event>
                <sub_title>Blood pressure increased</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="311"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="315"/>
              </event>
              <event>
                <sub_title>Sputum culture positive</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="311"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="315"/>
              </event>
              <event>
                <sub_title>Total</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="311"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="315"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Metabolism and nutrition disorders</title>
            <event_list>
              <event>
                <sub_title>Dehydration</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="311"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="315"/>
              </event>
              <event>
                <sub_title>Fluid overload</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="311"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="315"/>
              </event>
              <event>
                <sub_title>Total</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="311"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="315"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Musculoskeletal and connective tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Rhabdomyolysis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="311"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="315"/>
              </event>
              <event>
                <sub_title>Total</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="311"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="315"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Neoplasms benign, malignant and unspecified (incl cysts and polyps)</title>
            <event_list>
              <event>
                <sub_title>Benign cardiac neoplasm</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="311"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="315"/>
              </event>
              <event>
                <sub_title>Metastases to central nervous system</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="311"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="315"/>
              </event>
              <event>
                <sub_title>Pancreatic carcinoma</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="311"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="315"/>
              </event>
              <event>
                <sub_title>Rectal cancer</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="311"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="315"/>
              </event>
              <event>
                <sub_title>Total</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="311"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="315"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>Autonomic nervous system imbalance</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="311"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="315"/>
              </event>
              <event>
                <sub_title>Basilar artery thrombosis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="311"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="315"/>
              </event>
              <event>
                <sub_title>Brain oedema</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="311"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="315"/>
              </event>
              <event>
                <sub_title>Carotid arterial embolus</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="311"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="315"/>
              </event>
              <event>
                <sub_title>Carotid artery dissection</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="311"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="315"/>
              </event>
              <event>
                <sub_title>Carotid artery thrombosis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="311"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="315"/>
              </event>
              <event>
                <sub_title>Cerebral artery embolism</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="311"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="315"/>
              </event>
              <event>
                <sub_title>Cerebral artery thrombosis</sub_title>
                <counts group_id="E1" events="9" subjects_affected="9" subjects_at_risk="311"/>
                <counts group_id="E2" events="8" subjects_affected="8" subjects_at_risk="315"/>
              </event>
              <event>
                <sub_title>Cerebrovascular accident</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="311"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="315"/>
              </event>
              <event>
                <sub_title>Diplegia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="311"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="315"/>
              </event>
              <event>
                <sub_title>Embolic stroke</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="311"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="315"/>
              </event>
              <event>
                <sub_title>Encephalopathy</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="311"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="315"/>
              </event>
              <event>
                <sub_title>Haemorrhagic stroke</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="311"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="315"/>
              </event>
              <event>
                <sub_title>Headache</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="311"/>
                <counts group_id="E2" events="6" subjects_affected="6" subjects_at_risk="315"/>
              </event>
              <event>
                <sub_title>Hemiparesis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="311"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="315"/>
              </event>
              <event>
                <sub_title>Hydrocephalus</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="311"/>
                <counts group_id="E2" events="6" subjects_affected="6" subjects_at_risk="315"/>
              </event>
              <event>
                <sub_title>IIIrd nerve disorder</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="311"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="315"/>
              </event>
              <event>
                <sub_title>Intracranial aneurysm</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="311"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="315"/>
              </event>
              <event>
                <sub_title>Intracranial pressure increased</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="311"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="315"/>
              </event>
              <event>
                <sub_title>Ischaemic neuropathy</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="311"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="315"/>
              </event>
              <event>
                <sub_title>Ischaemic stroke</sub_title>
                <counts group_id="E1" events="16" subjects_affected="16" subjects_at_risk="311"/>
                <counts group_id="E2" events="15" subjects_affected="14" subjects_at_risk="315"/>
              </event>
              <event>
                <sub_title>Lethargy</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="311"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="315"/>
              </event>
              <event>
                <sub_title>Loss of consciousness</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="311"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="315"/>
              </event>
              <event>
                <sub_title>Memory impairment</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="311"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="315"/>
              </event>
              <event>
                <sub_title>Nervous system disorder</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="311"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="315"/>
              </event>
              <event>
                <sub_title>Neurological symptom</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="311"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="315"/>
              </event>
              <event>
                <sub_title>Paralysis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="311"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="315"/>
              </event>
              <event>
                <sub_title>Ruptured cerebral aneurysm</sub_title>
                <counts group_id="E1" events="8" subjects_affected="8" subjects_at_risk="311"/>
                <counts group_id="E2" events="9" subjects_affected="9" subjects_at_risk="315"/>
              </event>
              <event>
                <sub_title>Subarachnoid haemorrhage</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="311"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="315"/>
              </event>
              <event>
                <sub_title>Transient ischaemic attack</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="311"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="315"/>
              </event>
              <event>
                <sub_title>Total</sub_title>
                <counts group_id="E1" events="64" subjects_affected="52" subjects_at_risk="311"/>
                <counts group_id="E2" events="69" subjects_affected="53" subjects_at_risk="315"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Psychiatric disorders</title>
            <event_list>
              <event>
                <sub_title>Confusional state</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="311"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="315"/>
              </event>
              <event>
                <sub_title>Total</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="311"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="315"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Renal and urinary disorders</title>
            <event_list>
              <event>
                <sub_title>Renal failure</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="311"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="315"/>
              </event>
              <event>
                <sub_title>Total</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="311"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="315"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Reproductive system and breast disorders</title>
            <event_list>
              <event>
                <sub_title>Cervical dysplasia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="311"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="315"/>
              </event>
              <event>
                <sub_title>Total</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="311"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="315"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>Acute respiratory failure</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="311"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="315"/>
              </event>
              <event>
                <sub_title>Atelectasis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="311"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="315"/>
              </event>
              <event>
                <sub_title>Chronic obstructive pulmonary disease</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="311"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="315"/>
              </event>
              <event>
                <sub_title>Cryptogenic organising pneumonia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="311"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="315"/>
              </event>
              <event>
                <sub_title>Epistaxis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="311"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="315"/>
              </event>
              <event>
                <sub_title>Hypoxia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="311"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="315"/>
              </event>
              <event>
                <sub_title>Laryngospasm</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="311"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="315"/>
              </event>
              <event>
                <sub_title>Pneumonia aspiration</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="311"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="315"/>
              </event>
              <event>
                <sub_title>Pulmonary embolism</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="311"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="315"/>
              </event>
              <event>
                <sub_title>Pulmonary oedema</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="311"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="315"/>
              </event>
              <event>
                <sub_title>Respiratory distress</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="311"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="315"/>
              </event>
              <event>
                <sub_title>Respiratory failure</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="311"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="315"/>
              </event>
              <event>
                <sub_title>Total</sub_title>
                <counts group_id="E1" events="8" subjects_affected="6" subjects_at_risk="311"/>
                <counts group_id="E2" events="6" subjects_affected="6" subjects_at_risk="315"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Vascular disorders</title>
            <event_list>
              <event>
                <sub_title>Artery dissection</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="311"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="315"/>
              </event>
              <event>
                <sub_title>Deep vein thrombosis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="311"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="315"/>
              </event>
              <event>
                <sub_title>Femoral artery aneurysm</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="311"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="315"/>
              </event>
              <event>
                <sub_title>Femoral artery occlusion</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="311"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="315"/>
              </event>
              <event>
                <sub_title>Iliac artery stenosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="311"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="315"/>
              </event>
              <event>
                <sub_title>Peripheral vascular disorder</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="311"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="315"/>
              </event>
              <event>
                <sub_title>Thrombophlebitis superficial</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="311"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="315"/>
              </event>
              <event>
                <sub_title>Vascular pseudoaneurysm</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="311"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="315"/>
              </event>
              <event>
                <sub_title>Vasospasm</sub_title>
                <counts group_id="E1" events="19" subjects_affected="18" subjects_at_risk="311"/>
                <counts group_id="E2" events="29" subjects_affected="20" subjects_at_risk="315"/>
              </event>
              <event>
                <sub_title>Venous thrombosis limb</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="311"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="315"/>
              </event>
              <event>
                <sub_title>Vessel perforation</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="311"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="315"/>
              </event>
              <event>
                <sub_title>Total</sub_title>
                <counts group_id="E1" events="27" subjects_affected="24" subjects_at_risk="311"/>
                <counts group_id="E2" events="34" subjects_affected="24" subjects_at_risk="315"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="112" subjects_at_risk="311"/>
                <counts group_id="E2" subjects_affected="120" subjects_at_risk="315"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Blood and lymphatic system disorders</title>
            <event_list>
              <event>
                <sub_title>Anaemia</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="311"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="315"/>
              </event>
              <event>
                <sub_title>Leukocytosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="311"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="315"/>
              </event>
              <event>
                <sub_title>Total</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="311"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="315"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>Angina pectoris</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="311"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="315"/>
              </event>
              <event>
                <sub_title>Arrhythmia supraventricular</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="311"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="315"/>
              </event>
              <event>
                <sub_title>Atrial fibrillation</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="311"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="315"/>
              </event>
              <event>
                <sub_title>Bradycardia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="311"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="315"/>
              </event>
              <event>
                <sub_title>Cardiac failure congestive</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="311"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="315"/>
              </event>
              <event>
                <sub_title>Sinus tachycardia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="311"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="315"/>
              </event>
              <event>
                <sub_title>Supraventricular tachycardia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="311"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="315"/>
              </event>
              <event>
                <sub_title>Tachycardia</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="311"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="315"/>
              </event>
              <event>
                <sub_title>Total</sub_title>
                <counts group_id="E1" events="8" subjects_affected="7" subjects_at_risk="311"/>
                <counts group_id="E2" events="7" subjects_affected="7" subjects_at_risk="315"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Ear and labyrinth disorders</title>
            <event_list>
              <event>
                <sub_title>Ear pain</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="311"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="315"/>
              </event>
              <event>
                <sub_title>Tinnitus</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="311"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="315"/>
              </event>
              <event>
                <sub_title>Vertigo</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="311"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="315"/>
              </event>
              <event>
                <sub_title>Total</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="311"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="315"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Endocrine disorders</title>
            <event_list>
              <event>
                <sub_title>Diabetes insipidus</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="311"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="315"/>
              </event>
              <event>
                <sub_title>Total</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="311"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="315"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Eye disorders</title>
            <event_list>
              <event>
                <sub_title>Blindness unilateral</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="311"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="315"/>
              </event>
              <event>
                <sub_title>Diplopia</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="311"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="315"/>
              </event>
              <event>
                <sub_title>Eye pain</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="311"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="315"/>
              </event>
              <event>
                <sub_title>Eye swelling</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="311"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="315"/>
              </event>
              <event>
                <sub_title>Macular degeneration</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="311"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="315"/>
              </event>
              <event>
                <sub_title>Photophobia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="311"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="315"/>
              </event>
              <event>
                <sub_title>Photopsia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="311"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="315"/>
              </event>
              <event>
                <sub_title>Retinal artery occlusion</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="311"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="315"/>
              </event>
              <event>
                <sub_title>Retinal haemorrhage</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="311"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="315"/>
              </event>
              <event>
                <sub_title>Strabismus</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="311"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="315"/>
              </event>
              <event>
                <sub_title>Vision blurred</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="311"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="315"/>
              </event>
              <event>
                <sub_title>Visual disturbance</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="311"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="315"/>
              </event>
              <event>
                <sub_title>Vitreous floaters</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="311"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="315"/>
              </event>
              <event>
                <sub_title>Total</sub_title>
                <counts group_id="E1" events="13" subjects_affected="10" subjects_at_risk="311"/>
                <counts group_id="E2" events="16" subjects_affected="15" subjects_at_risk="315"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Abdominal pain</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="311"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="315"/>
              </event>
              <event>
                <sub_title>Abdominal pain upper</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="311"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="315"/>
              </event>
              <event>
                <sub_title>Constipation</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="311"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="315"/>
              </event>
              <event>
                <sub_title>Diarrhoea</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="311"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="315"/>
              </event>
              <event>
                <sub_title>Gastritis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="311"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="315"/>
              </event>
              <event>
                <sub_title>Hernial eventration</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="311"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="315"/>
              </event>
              <event>
                <sub_title>Nausea</sub_title>
                <counts group_id="E1" events="10" subjects_affected="10" subjects_at_risk="311"/>
                <counts group_id="E2" events="10" subjects_affected="10" subjects_at_risk="315"/>
              </event>
              <event>
                <sub_title>Tongue disorder</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="311"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="315"/>
              </event>
              <event>
                <sub_title>Vomiting</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="311"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="315"/>
              </event>
              <event>
                <sub_title>Total</sub_title>
                <counts group_id="E1" events="20" subjects_affected="14" subjects_at_risk="311"/>
                <counts group_id="E2" events="16" subjects_affected="13" subjects_at_risk="315"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Adverse drug reaction</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="311"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="315"/>
              </event>
              <event>
                <sub_title>Asthenia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="311"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="315"/>
              </event>
              <event>
                <sub_title>Catheter site discharge</sub_title>
                <counts group_id="E1" events="6" subjects_affected="6" subjects_at_risk="311"/>
                <counts group_id="E2" events="10" subjects_affected="10" subjects_at_risk="315"/>
              </event>
              <event>
                <sub_title>Catheter site haematoma</sub_title>
                <counts group_id="E1" events="12" subjects_affected="12" subjects_at_risk="311"/>
                <counts group_id="E2" events="16" subjects_affected="16" subjects_at_risk="315"/>
              </event>
              <event>
                <sub_title>Catheter site haemorrhage</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="311"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="315"/>
              </event>
              <event>
                <sub_title>Catheter site pain</sub_title>
                <counts group_id="E1" events="8" subjects_affected="8" subjects_at_risk="311"/>
                <counts group_id="E2" events="6" subjects_affected="6" subjects_at_risk="315"/>
              </event>
              <event>
                <sub_title>Catheter site rash</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="311"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="315"/>
              </event>
              <event>
                <sub_title>Chest pain</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="311"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="315"/>
              </event>
              <event>
                <sub_title>Fatigue</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="311"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="315"/>
              </event>
              <event>
                <sub_title>Hyperthermia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="311"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="315"/>
              </event>
              <event>
                <sub_title>Infusion site extravasation</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="311"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="315"/>
              </event>
              <event>
                <sub_title>Oedema peripheral</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="311"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="315"/>
              </event>
              <event>
                <sub_title>Peripheral coldness</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="311"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="315"/>
              </event>
              <event>
                <sub_title>Pyrexia</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="311"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="315"/>
              </event>
              <event>
                <sub_title>Total</sub_title>
                <counts group_id="E1" events="43" subjects_affected="33" subjects_at_risk="311"/>
                <counts group_id="E2" events="40" subjects_affected="31" subjects_at_risk="315"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Immune system disorders</title>
            <event_list>
              <event>
                <sub_title>Contrast media allergy</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="311"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="315"/>
              </event>
              <event>
                <sub_title>Drug hypersensitivity</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="311"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="315"/>
              </event>
              <event>
                <sub_title>Hypersensitivity</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="311"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="315"/>
              </event>
              <event>
                <sub_title>Total</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="311"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="315"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>Bacteraemia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="311"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="315"/>
              </event>
              <event>
                <sub_title>Catheter site infection</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="311"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="315"/>
              </event>
              <event>
                <sub_title>Clostridium difficile colitis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="311"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="315"/>
              </event>
              <event>
                <sub_title>Ear infection</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="311"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="315"/>
              </event>
              <event>
                <sub_title>Hepatitis E</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="311"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="315"/>
              </event>
              <event>
                <sub_title>Infusion site infection</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="311"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="315"/>
              </event>
              <event>
                <sub_title>Lung infection</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="311"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="315"/>
              </event>
              <event>
                <sub_title>Meningitis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="311"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="315"/>
              </event>
              <event>
                <sub_title>Nasopharyngitis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="311"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="315"/>
              </event>
              <event>
                <sub_title>Oral candidiasis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="311"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="315"/>
              </event>
              <event>
                <sub_title>Pneumonia</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="311"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="315"/>
              </event>
              <event>
                <sub_title>Respiratory tract infection</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="311"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="315"/>
              </event>
              <event>
                <sub_title>Tracheitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="311"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="315"/>
              </event>
              <event>
                <sub_title>Upper respiratory tract infection</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="311"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="315"/>
              </event>
              <event>
                <sub_title>Upper respiratory tract infection bact</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="311"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="315"/>
              </event>
              <event>
                <sub_title>Urinary tract infection</sub_title>
                <counts group_id="E1" events="9" subjects_affected="8" subjects_at_risk="311"/>
                <counts group_id="E2" events="9" subjects_affected="9" subjects_at_risk="315"/>
              </event>
              <event>
                <sub_title>Viral infection</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="311"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="315"/>
              </event>
              <event>
                <sub_title>Total</sub_title>
                <counts group_id="E1" events="25" subjects_affected="21" subjects_at_risk="311"/>
                <counts group_id="E2" events="18" subjects_affected="15" subjects_at_risk="315"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Injury, poisoning and procedural complications</title>
            <event_list>
              <event>
                <sub_title>Ankle fracture</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="311"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="315"/>
              </event>
              <event>
                <sub_title>Contusion</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="311"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="315"/>
              </event>
              <event>
                <sub_title>Patella fracture</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="311"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="315"/>
              </event>
              <event>
                <sub_title>Procedural hypertension</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="311"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="315"/>
              </event>
              <event>
                <sub_title>Procedural hypotension</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="311"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="315"/>
              </event>
              <event>
                <sub_title>Procedural nausea</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="311"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="315"/>
              </event>
              <event>
                <sub_title>Radiation skin injury</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="311"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="315"/>
              </event>
              <event>
                <sub_title>Scratch</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="311"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="315"/>
              </event>
              <event>
                <sub_title>Skeletal injury</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="311"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="315"/>
              </event>
              <event>
                <sub_title>Total</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="311"/>
                <counts group_id="E2" events="10" subjects_affected="10" subjects_at_risk="315"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Investigations</title>
            <event_list>
              <event>
                <sub_title>Electrocardiogram ST segment abnormal</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="311"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="315"/>
              </event>
              <event>
                <sub_title>Troponin increased</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="311"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="315"/>
              </event>
              <event>
                <sub_title>Ultrasound Doppler abnormal</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="311"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="315"/>
              </event>
              <event>
                <sub_title>Urine sodium increased</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="311"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="315"/>
              </event>
              <event>
                <sub_title>Total</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="311"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="315"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Metabolism and nutrition disorders</title>
            <event_list>
              <event>
                <sub_title>Dehydration</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="311"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="315"/>
              </event>
              <event>
                <sub_title>Electrolyte imbalance</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="311"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="315"/>
              </event>
              <event>
                <sub_title>Fluid overload</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="311"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="315"/>
              </event>
              <event>
                <sub_title>Hyperchloraemia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="311"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="315"/>
              </event>
              <event>
                <sub_title>Hyperglycaemia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="311"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="315"/>
              </event>
              <event>
                <sub_title>Hyperkalaemia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="311"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="315"/>
              </event>
              <event>
                <sub_title>Hypermagnesaemia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="311"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="315"/>
              </event>
              <event>
                <sub_title>Hypocalcaemia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="311"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="315"/>
              </event>
              <event>
                <sub_title>Hypokalaemia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="311"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="315"/>
              </event>
              <event>
                <sub_title>Hyponatraemia</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="311"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="315"/>
              </event>
              <event>
                <sub_title>Hypophosphataemia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="311"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="315"/>
              </event>
              <event>
                <sub_title>Metabolic disorder</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="311"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="315"/>
              </event>
              <event>
                <sub_title>Total</sub_title>
                <counts group_id="E1" events="12" subjects_affected="7" subjects_at_risk="311"/>
                <counts group_id="E2" events="13" subjects_affected="7" subjects_at_risk="315"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Musculoskeletal and connective tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Arthralgia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="311"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="315"/>
              </event>
              <event>
                <sub_title>Back pain</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="311"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="315"/>
              </event>
              <event>
                <sub_title>Fibromyalgia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="311"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="315"/>
              </event>
              <event>
                <sub_title>Muscle spasms</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="311"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="315"/>
              </event>
              <event>
                <sub_title>Muscle twitching</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="311"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="315"/>
              </event>
              <event>
                <sub_title>Musculoskeletal pain</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="311"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="315"/>
              </event>
              <event>
                <sub_title>Musculoskeletal stiffness</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="311"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="315"/>
              </event>
              <event>
                <sub_title>Neck pain</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="311"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="315"/>
              </event>
              <event>
                <sub_title>Osteoporotic fracture</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="311"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="315"/>
              </event>
              <event>
                <sub_title>Pain in extremity</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="311"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="315"/>
              </event>
              <event>
                <sub_title>Pain in jaw</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="311"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="315"/>
              </event>
              <event>
                <sub_title>Total</sub_title>
                <counts group_id="E1" events="6" subjects_affected="5" subjects_at_risk="311"/>
                <counts group_id="E2" events="14" subjects_affected="13" subjects_at_risk="315"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>Balance disorder</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="311"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="315"/>
              </event>
              <event>
                <sub_title>Brain oedema</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="311"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="315"/>
              </event>
              <event>
                <sub_title>CNS ventriculitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="311"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="315"/>
              </event>
              <event>
                <sub_title>Carotid artery dissection</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="311"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="315"/>
              </event>
              <event>
                <sub_title>Carotid artery thrombosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="311"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="315"/>
              </event>
              <event>
                <sub_title>Cerebral artery embolism</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="311"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="315"/>
              </event>
              <event>
                <sub_title>Cerebral artery occlusion</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="311"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="315"/>
              </event>
              <event>
                <sub_title>Cerebral artery stenosis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="311"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="315"/>
              </event>
              <event>
                <sub_title>Cerebral artery thrombosis</sub_title>
                <counts group_id="E1" events="7" subjects_affected="7" subjects_at_risk="311"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="315"/>
              </event>
              <event>
                <sub_title>Convulsion</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="311"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="315"/>
              </event>
              <event>
                <sub_title>Coordination abnormal</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="311"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="315"/>
              </event>
              <event>
                <sub_title>Dizziness</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="311"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="315"/>
              </event>
              <event>
                <sub_title>Embolic stroke</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="311"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="315"/>
              </event>
              <event>
                <sub_title>Headache</sub_title>
                <counts group_id="E1" events="59" subjects_affected="54" subjects_at_risk="311"/>
                <counts group_id="E2" events="68" subjects_affected="57" subjects_at_risk="315"/>
              </event>
              <event>
                <sub_title>Hydrocephalus</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="311"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="315"/>
              </event>
              <event>
                <sub_title>Hypoaesthesia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="311"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="315"/>
              </event>
              <event>
                <sub_title>Intracranial aneurysm</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="311"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="315"/>
              </event>
              <event>
                <sub_title>Intracranial pressure increased</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="311"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="315"/>
              </event>
              <event>
                <sub_title>Ischaemic stroke</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="311"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="315"/>
              </event>
              <event>
                <sub_title>Lethargy</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="311"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="315"/>
              </event>
              <event>
                <sub_title>Memory impairment</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="311"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="315"/>
              </event>
              <event>
                <sub_title>Migraine</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="311"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="315"/>
              </event>
              <event>
                <sub_title>Paraesthesia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="311"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="315"/>
              </event>
              <event>
                <sub_title>Peroneal nerve palsy</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="311"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="315"/>
              </event>
              <event>
                <sub_title>Ruptured cerebral aneurysm</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="311"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="315"/>
              </event>
              <event>
                <sub_title>Sciatica</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="311"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="315"/>
              </event>
              <event>
                <sub_title>Sensory loss</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="311"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="315"/>
              </event>
              <event>
                <sub_title>Syncope</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="311"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="315"/>
              </event>
              <event>
                <sub_title>Transient ischaemic attack</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="311"/>
                <counts group_id="E2" events="5" subjects_affected="4" subjects_at_risk="315"/>
              </event>
              <event>
                <sub_title>Tremor</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="311"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="315"/>
              </event>
              <event>
                <sub_title>VIth nerve paralysis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="311"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="315"/>
              </event>
              <event>
                <sub_title>Total</sub_title>
                <counts group_id="E1" events="89" subjects_affected="73" subjects_at_risk="311"/>
                <counts group_id="E2" events="100" subjects_affected="78" subjects_at_risk="315"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Psychiatric disorders</title>
            <event_list>
              <event>
                <sub_title>Alcohol withdrawal syndrome</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="311"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="315"/>
              </event>
              <event>
                <sub_title>Anxiety</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="311"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="315"/>
              </event>
              <event>
                <sub_title>Confusional state</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="311"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="315"/>
              </event>
              <event>
                <sub_title>Delirium</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="311"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="315"/>
              </event>
              <event>
                <sub_title>Depression</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="311"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="315"/>
              </event>
              <event>
                <sub_title>Insomnia</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="311"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="315"/>
              </event>
              <event>
                <sub_title>Mental status changes</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="311"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="315"/>
              </event>
              <event>
                <sub_title>Sleep disorder</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="311"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="315"/>
              </event>
              <event>
                <sub_title>Total</sub_title>
                <counts group_id="E1" events="7" subjects_affected="7" subjects_at_risk="311"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="315"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Renal and urinary disorders</title>
            <event_list>
              <event>
                <sub_title>Renal failure</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="311"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="315"/>
              </event>
              <event>
                <sub_title>Urethral haemorrhage</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="311"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="315"/>
              </event>
              <event>
                <sub_title>Urinary retention</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="311"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="315"/>
              </event>
              <event>
                <sub_title>Total</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="311"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="315"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>Aspiration</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="311"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="315"/>
              </event>
              <event>
                <sub_title>Dyspnoea</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="311"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="315"/>
              </event>
              <event>
                <sub_title>Epistaxis</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="311"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="315"/>
              </event>
              <event>
                <sub_title>Haemoptysis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="311"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="315"/>
              </event>
              <event>
                <sub_title>Pharyngolaryngeal pain</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="311"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="315"/>
              </event>
              <event>
                <sub_title>Pneumonia aspiration</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="311"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="315"/>
              </event>
              <event>
                <sub_title>Total</sub_title>
                <counts group_id="E1" events="8" subjects_affected="8" subjects_at_risk="311"/>
                <counts group_id="E2" events="8" subjects_affected="7" subjects_at_risk="315"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Skin and subcutaneous tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Alopecia</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="311"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="315"/>
              </event>
              <event>
                <sub_title>Ecchymosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="311"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="315"/>
              </event>
              <event>
                <sub_title>Increased tendency to bruise</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="311"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="315"/>
              </event>
              <event>
                <sub_title>Rash</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="311"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="315"/>
              </event>
              <event>
                <sub_title>Rash generalised</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="311"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="315"/>
              </event>
              <event>
                <sub_title>Swelling face</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="311"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="315"/>
              </event>
              <event>
                <sub_title>Urticaria</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="311"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="315"/>
              </event>
              <event>
                <sub_title>Total</sub_title>
                <counts group_id="E1" events="6" subjects_affected="6" subjects_at_risk="311"/>
                <counts group_id="E2" events="9" subjects_affected="9" subjects_at_risk="315"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Vascular disorders</title>
            <event_list>
              <event>
                <sub_title>Artery dissection</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="311"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="315"/>
              </event>
              <event>
                <sub_title>Blood pressure fluctuation</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="311"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="315"/>
              </event>
              <event>
                <sub_title>Hot flush</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="311"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="315"/>
              </event>
              <event>
                <sub_title>Hypertension</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="311"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="315"/>
              </event>
              <event>
                <sub_title>Hypotension</sub_title>
                <counts group_id="E1" events="6" subjects_affected="6" subjects_at_risk="311"/>
                <counts group_id="E2" events="7" subjects_affected="7" subjects_at_risk="315"/>
              </event>
              <event>
                <sub_title>Intermittent claudication</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="311"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="315"/>
              </event>
              <event>
                <sub_title>Peripheral artery aneurysm</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="311"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="315"/>
              </event>
              <event>
                <sub_title>Phlebitis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="311"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="315"/>
              </event>
              <event>
                <sub_title>Vasospasm</sub_title>
                <counts group_id="E1" events="9" subjects_affected="9" subjects_at_risk="311"/>
                <counts group_id="E2" events="8" subjects_affected="8" subjects_at_risk="315"/>
              </event>
              <event>
                <sub_title>Total</sub_title>
                <counts group_id="E1" events="23" subjects_affected="23" subjects_at_risk="311"/>
                <counts group_id="E2" events="17" subjects_affected="17" subjects_at_risk="315"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.</restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>S. Claiboren Johnston, MD, PhD</name_or_title>
      <organization>University of California, UCSF Medical Center</organization>
      <phone>415-502-7487</phone>
      <email>Clay.Johnston@ucsfmedctr.org</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

